Condition
Solid Advanced Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Solid Advanced Tumor clinical trials that are recruiting, at sites in 4 countries (most in China (1), Belgium (1), France (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
MCLA-129 plus ensartinib for MET‑amplified or MET‑overexpressing advanced solid tumors
This trial tests whether combining the antibody MCLA-129 with the drug ensartinib helps people with advanced solid tumors that have MET amplification or MET overexpression.
-
Testing OSE-279 for advanced solid tumors and lymphomas
This study is testing a new treatment called OSE-279 to see if it can help people with advanced solid tumors or lymphomas who haven't had success with other therapies.
Related topics
Quick answers
How many Solid Advanced Tumor clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), Belgium (1 trial), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.